Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Mar 23, 2007

FMC Lithium Commissions India Facility

  • FMC Lithium commissioned its first factory in India, near Hyderabad, to manufacture organolithium compounds that are primarily used in the bulk drug industry.

    According to FMC, the organolithium sector of the India pharmaceutical market is growing rapidly due to the extensive production of drugs that treat cardiovascular diseases and HIV infection. FMC has been supplying major producers in India through imports from the U.S., but the new facility will make it much easier for the company to service the growing demand of customers in India while efficiently managing its supply chain, explains an FMC official.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »